🔎 Trials Near Me

Akèy › Kansè Metastatik › Kalifòni › Irvine

Etid klinik pou Kansè Metastatik nan Irvine, CA

16 etid pou Kansè Metastatik ap chèche patisipan nan sit nan ak bò kote Irvine (nan yon distans apeprè 30 mil). Louvri yon etid pou wè ki moun ki ka patisipe ak kijan pou kontakte ekip etid la.

Tèks ofisyèl etid la (Anglè)

Ap chèche patisipan pou yon etid? Mete l anwo paj sa a — $99 pou 30 jou →

Testing the Safety and Tolerability of the Anti-cancer Drugs Trastuzumab Deruxtecan and Neratinib for Cancers With Changes in the HER2 Gene

Ap rekriteFaz 1
  • UCI Health - Chao Family Comprehensive Cancer Center and Ambulatory Care, Irvine
  • City of Hope at Irvine Lennar, Irvine
Laj 18 ak plis · Tout sèks · Mizajou Oct 2, 2026 · NCT05372614

Testing the Addition of an Anti-Cancer Drug, ZEN003694, to the Usual Chemotherapy Treatment (Capecitabine) for Metastatic or Unresectable Cancers

Ap rekriteFaz 1
  • UCI Health - Chao Family Comprehensive Cancer Center and Ambulatory Care, Irvine
Laj 18 ak plis · Tout sèks · Mizajou Sep 29, 2026 · NCT05803382

A Study to Learn About the Medicine Ponsegromab in Adults With Cancer of the Pancreas Which Has Spread and Caused Significant Body Weight Loss and Fatigue

Ap rekriteFaz 2/3
  • Chao Family Comprehensive Cancer Center and Ambulatory Care, Irvine
  • UCI Health - Irvine, Irvine
Laj 18 ak plis · Tout sèks · Mizajou Sep 25, 2026 · NCT06989437

A Three-Part Phase 3 Study of Sofetabart Mipitecan in Participants With Platinum-Resistant (Part A) and Platinum-Sensitive (Parts B and C) Ovarian Cancer

Ap rekriteFaz 3
  • City of Hope Lennar, Irvine
  • Kaiser Permanente Zion Medical Center, Irvine
Laj 18 ak plis · Tout sèks · Mizajou Sep 22, 2026 · NCT07213804

A Study of Vepugratinib (LY3866288) in Participants With Cancer in the Urinary Tract

Ap rekriteFaz 3
  • Chao Family Comprehensive Cancer Center and Ambulatory Care (CIACC) - Irvine, Irvine
Laj 18 ak plis · Tout sèks · Mizajou Sep 22, 2026 · NCT07218380

A Study of Tersolisib (LY4064809/STX-478) With Other Anti-Cancer Treatments in Participants With Advanced Breast Cancer With a Genetic Change (PIK3CA)

Ap rekriteFaz 3
  • Chao Family Comprehensive Cancer Center and Ambulatory Care (CIACC) - Irvine, Irvine
  • City of Hope Orange County Lennar Foundation Cancer Center, Irvine
Laj 18 ak plis · Tout sèks · Mizajou Sep 22, 2026 · NCT07174336

AMG 436 as Monotherapy and Combination Therapy in Participants With MSI-H/dMMR Solid Tumors

Ap rekriteFaz 1
  • City of Hope Orange County Lennar Foundation Cancer Center, Irvine
Laj 18 a 99 · Tout sèks · Mizajou Sep 21, 2026 · NCT07403721

Symbiotic-GU-08: A Study to Learn About the Medicine Called PF-08634404 Dosed Alone and in Combination With Other Anticancer Therapies in Adults With Locally Advanced or Metastatic Renal Cell Cancer

Ap rekriteFaz 1/2
  • City of Hope at Irvine Lennar, Irvine
  • City of Hope Investigational Drug Services (IDS), Irvine
Laj 18 ak plis · Tout sèks · Mizajou Sep 17, 2026 · NCT07227415

A Study Evaluating the Efficacy and Safety of Multiple Treatment Combinations in Participants With Breast Cancer

Ap rekriteFaz 1/2
  • City of Hope - Orange County Lennar Foundation Cancer Center, Irvine
Laj 18 ak plis · Fanm · Mizajou Sep 3, 2026 · NCT04802759

Study of the Bria-IMT Regimen and CPI vs Physicians' Choice in Advanced Metastatic Breast Cancer.

Ap rekriteFaz 3
  • Hoag Hospital Center, Irvine
  • Hoag Hospital Irvine, Irvine
Laj 18 ak plis · Tout sèks · Mizajou Sep 2, 2026 · NCT06072612

Testing the Combination of the Anti-Cancer Drugs Temozolomide and M1774 to Evaluate Their Safety and Effectiveness

Ap rekriteFaz 1/2
  • UCI Health - Chao Family Comprehensive Cancer Center and Ambulatory Care, Irvine
Laj 18 ak plis · Tout sèks · Mizajou Jul 31, 2026 · NCT05691491

A Study of NVL-330 in Patients With Advanced or Metastatic HER2-altered NSCLC (HEROEX-1)

Ap rekriteFaz 1
  • City of Hope - Lennar, Irvine
Laj 18 ak plis · Tout sèks · Mizajou Feb 25, 2026 · NCT06521554

SYNERGY-AI: Artificial Intelligence Based Precision Oncology Clinical Trial Matching and Registry

Ap rekriteEtid obsèvasyon
  • Massive Bio SYNERGY-AI site, Irvine
Tout laj · Tout sèks · Mizajou Oct 28, 2025 · NCT03452774

Phase 1 Study Evaluating BA3182 in Patients With Advanced Adenocarcinoma.

Ap rekriteFaz 1
  • UC Irvine, Irvine
Laj 18 ak plis · Tout sèks · Mizajou Sep 25, 2025 · NCT05808634

Safety, Tolerability, and Preliminary Efficacy of CJRB-101 With Pembrolizumab in Subjects With Selected Types of Advanced or Metastatic Cancer

Ap rekriteFaz 1/2
  • University of California, Irvine, Irvine
Laj 18 ak plis · Tout sèks · Mizajou Dec 20, 2024 · NCT05877430

Etid Kansè Metastatik nan lòt vil

Lòt etid nan Irvine

Sous ClinicalTrials.gov, done yo ranmase Oct 6, 2026. Chak etid gen kritè li pou li menm; ekip etid la deside ki moun ki ka patisipe.